MEDBOT-B (02252.HK) +0.240 (+0.900%) Short selling $23.47M; Ratio 11.160% opened 6.7% higher today before its gains sharply expanded in the morning session. The stock rose above both the 50-day and 100-day MAs (approx. $23.75 and $24.75 each), and expanded the downward trendline formed since October. It peaked at $27.8, hitting a nearly-2-month high, and last snowballed 30.19% to close at $27.6 near midday. Trading volume surged to 17.6027 million shares, involving $444 million.On Christmas Eve (24 December), MEDBOT-B announced that its self-developed bronchoscopic surgical robot, UniPathTM Electronic Bronchoscopic Surgical Robotic System (UniPath), has been officially approved by China's National Medical Products Administration (NMPA).Brain-computer interface concept stocks listed on the A-share market broadly prospered. XYME (688626.SH) +0.550 (+0.928%) shot up 8.5% at midday, while MEHOW (301363.SZ) -0.130 (-0.519%) and INNOVATIVE MEDICAL (002173.SZ) -0.470 (-2.104%) closed up 5.1%. CENTURY HUATONG (002602.SZ) -0.050 (-0.285%) , HANWEI ELECTRONICS (300007.SZ) +3.900 (+7.644%) and APON MEDICAL (300753.SZ) -0.650 (-2.250%) jumped up 2.6-3.8%.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-12-30 12:25.) (A Shares quote is delayed for at least 15 mins.)